Repligen (RGEN) Short Interest Ratio & Short Volume $148.70 -1.76 (-1.17%) (As of 03:09 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Repligen Short Interest DataRepligen (RGEN) has a short interest of 3.43 million shares, representing 6.58% of the float (the number of shares available for trading by the public). This marks a 3.94% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.9, indicating that it would take 4.9 days of the average trading volume of 662,401 shares to cover all short positions.Current Short Interest3,430,000 sharesPrevious Short Interest3,300,000 sharesChange Vs. Previous Month+3.94%Dollar Volume Sold Short$427.82 millionShort Interest Ratio4.9 Days to CoverLast Record DateNovember 15, 2024Outstanding Shares56,027,000 sharesFloat Size52,100,000 sharesShort Percent of Float6.58%Today's Trading Volume276,144 sharesAverage Trading Volume662,401 sharesToday's Volume Vs. Average42% Short Selling Repligen? Sign up to receive the latest short interest report for Repligen and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRGEN Short Interest Over TimeRGEN Days to Cover Over TimeRGEN Percentage of Float Shorted Over Time Ad WealthPressThe indicator behind Nvidia’s rally has a new prospectEvery now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Repligen Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/15/20243,430,000 shares $427.82 million +3.9%6.6%4.9 $124.73 10/31/20243,300,000 shares $443.09 million -4.6%6.3%4.9 $134.27 10/15/20243,460,000 shares $501.63 million -9.0%6.6%4.4 $144.98 9/30/20243,800,000 shares $565.52 million -3.1%7.3%4.7 $148.82 9/15/20243,920,000 shares $548.76 million -3.2%7.5%4.6 $139.99 8/31/20244,050,000 shares $611.27 million -8.0%7.8%4.4 $150.93 Get the Latest News and Ratings for RGEN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Repligen and its competitors with MarketBeat's FREE daily newsletter. 8/15/20244,400,000 shares $715.48 million +0.2%8.5%5.2 $162.61 7/31/20244,390,000 shares $734.67 million +3.8%8.4%5.6 $167.35 7/15/20244,230,000 shares $518.60 million +0.5%8.1%6.1 $122.60 6/30/20244,210,000 shares $530.71 million -0.9%8.1%6.5 $126.06 6/15/20244,250,000 shares $533.89 million -1.9%8.2%6.9 $125.62 5/31/20244,330,000 shares $645.56 million -0.5%8.3%8.9 $149.09 5/15/20244,350,000 shares $765.73 million -1.6%8.4%9.6 $176.03 4/30/20244,420,000 shares $725.76 million -3.7%8.5%8.9 $164.20 4/15/20244,590,000 shares $763.73 million -3.8%8.9%8.7 $166.39 3/31/20244,770,000 shares $877.30 million No Change9.2%8.8 $183.92 3/15/20244,770,000 shares $905.97 million -2.3%9.2%8.9 $189.93 2/29/20244,880,000 shares $946.67 million -8.8%9.4%8.1 $193.99 2/15/20245,350,000 shares $1.10 billion -7.9%10.3%8.8 $206.03 1/31/20245,810,000 shares $1.10 billion -0.2%11.2%9.8 $189.40 1/15/20245,820,000 shares $1.01 billion -2.7%11.2%8.7 $173.21 12/31/20235,980,000 shares $1.08 billion -2.1%11.5%8.7 $179.80 12/15/20236,110,000 shares $1.11 billion +1.8%11.8%9.1 $181.22 11/30/20236,000,000 shares $943.50 million +0.2%11.6%9.1 $157.25 11/15/20235,990,000 shares $934.02 million +0.3%11.5%9.7 $155.93 10/31/20235,970,000 shares $803.32 million -0.2%11.5%9.9 $134.56 10/15/20235,980,000 shares $913.39 million +2.2%11.5%11.5 $152.74 9/30/20235,850,000 shares $930.21 million +6.2%11.3%11.6 $159.01 9/15/20235,510,000 shares $911.91 million +1.3%10.6%10 $165.50 8/31/20235,440,000 shares $946.07 million +0.7%10.5%9.5 $173.91 8/15/20235,400,000 shares $934.42 million -1.8%10.4%8.9 $173.04 7/31/20235,500,000 shares $943.58 million +2.0%10.6%9.1 $171.56 7/15/20235,390,000 shares $811.14 million +0.9%10.4%8.4 $150.49 6/30/20235,340,000 shares $755.40 million -8.6%10.3%9 $141.46 6/15/20235,840,000 shares $940.59 million +5.0%11.3%10.5 $161.06 5/31/20235,560,000 shares $933.64 million +4.9%10.7%10.2 $167.92 5/15/20235,300,000 shares $816.36 million -1.1%10.2%9.1 $154.03 4/30/20235,360,000 shares $812.74 million +10.1%10.4%9.2 $151.63 4/15/20234,870,000 shares $847.53 million +9.2%9.4%8.7 $174.03 3/31/20234,460,000 shares $750.89 million +7.7%8.6%8.2 $168.36"Start Earning Extra Income with Just $30" (Ad)What if you could unlock a steady income stream from stocks priced under $30? Our new guide walks you through simple, effective options strategies designed for everyday investors. With step-by-step insights, you’ll learn how to transform familiar names like Ford and Intel into reliable monthly income generators.Claim Your Free Report Now: “Options Made Simple – 2 Affordable Stocks for Monthly Income” 3/15/20234,140,000 shares $706.62 million No Change8.0%7.5 $170.68 2/28/20234,140,000 shares $721.89 million +9.2%8.0%7.7 $174.37 2/15/20233,790,000 shares $742.84 million -6.4%7.3%6.5 $196.00 1/31/20234,050,000 shares $750.47 million -0.5%7.9%7.3 $185.30 1/15/20234,070,000 shares $724.70 million +11.2%7.9%6.9 $178.06 12/30/20223,660,000 shares $619.67 million +2.0%7.1%5.7 $169.31 12/15/20223,590,000 shares $604.02 million +11.5%7.0%5.7 $168.25 11/30/20223,220,000 shares $575.86 million -0.9%6.2%5 $178.84 11/15/20223,250,000 shares $685.23 million +4.2%6.3%5.7 $210.84 10/31/20223,120,000 shares $569.37 million +5.1%6.0%5.7 $182.49 10/15/20222,970,000 shares $574.81 million +11.7%5.8%5.2 $193.54 9/30/20222,660,000 shares $497.71 million +0.8%5.2%4.9 $187.11 9/15/20222,640,000 shares $613.06 million +1.2%5.1%5.1 $232.22 8/31/20222,610,000 shares $572.56 million -7.8%5.1%4.9 $219.37 8/15/20222,830,000 shares $723.72 million -12.4%5.5%5.3 $255.73 7/31/20223,230,000 shares $689.15 million +2.5%6.3%6.2 $213.36 7/15/20223,150,000 shares $525.36 million +10.5%6.1%5.9 $166.78 6/30/20222,850,000 shares $462.84 million +10.0%5.5%5.4 $162.40 6/15/20222,590,000 shares $383.35 million -1.2%6.6%4.8 $148.01 5/31/20222,620,000 shares $430.91 million +2.8%5.1%5.2 $164.47 5/15/20222,550,000 shares $383.52 million -8.3%5.0%5.1 $150.40 4/30/20222,780,000 shares $437.13 million +21.4%5.4%5.4 $157.24 4/15/20222,290,000 shares $361.06 million +3.6%4.5%5 $157.67 3/31/20222,210,000 shares $415.68 million -10.2%4.3%4.9 $188.09 3/15/20222,460,000 shares $417.76 million +5.1%4.8%5.5 $169.82 2/28/20222,340,000 shares $460.28 million +9.9%4.6%5.3 $196.70 2/15/20222,130,000 shares $398.42 million +1.9%4.2%4.8 $187.05 1/31/20222,090,000 shares $414.53 million +29.8%4.1%5 $198.34 1/15/20221,610,000 shares $311.15 million +6.6%3.1%3.7 $193.26 12/31/20211,510,000 shares $399.91 million -9.6%2.9%3.9 $264.84 12/15/20211,670,000 shares $437.26 million -5.1%3.3%4.3 $261.83 11/30/20211,760,000 shares $504.24 million +6.7%3.4%4.2 $286.50 11/15/20211,650,000 shares $431.39 million +3.8%3.2%4.2 $261.45 10/29/20211,590,000 shares $461.90 million -1.9%3.1%4.3 $290.50 10/15/20211,620,000 shares $432.41 million -3.6%3.2%4.4 $266.92 9/30/20211,680,000 shares $485.50 million +5.0%3.3%4.5 $288.99 9/15/20211,600,000 shares $474.24 million +1.9%3.1%4.7 $296.40 8/31/20211,570,000 shares $444.28 million -4.3%3.1%4.8 $282.98 8/13/20211,640,000 shares $423.05 million -4.7%3.2%4.6 $257.96 7/30/20211,720,000 shares $422.60 million +8.2%3.4%4.2 $245.70 7/15/20211,590,000 shares $313.40 million -6.5%3.1%4 $197.11 6/30/20211,700,000 shares $339.35 million -1.2%3.3%4.5 $199.62 6/15/20211,720,000 shares $326.18 million -1.2%3.4%4.2 $189.64 5/28/20211,740,000 shares $317.74 million +5.5%3.4%4.2 $182.61 5/14/20211,650,000 shares $279.92 million +5.8%3.2%3.9 $169.65 4/30/20211,560,000 shares $332.50 million -3.7%3.1%4 $213.14 4/15/20211,620,000 shares $332.57 million +4.5%3.2%4.2 $205.29 3/31/20211,550,000 shares $293.28 million +10.7%3.1%3.8 $189.21 3/15/20211,400,000 shares $272.58 million +3.7%2.8%3.5 $194.70 2/26/20211,350,000 shares $279.54 million -4.9%2.7%3.4 $207.07"Start Earning Extra Income with Just $30" (Ad)What if you could unlock a steady income stream from stocks priced under $30? Our new guide walks you through simple, effective options strategies designed for everyday investors. With step-by-step insights, you’ll learn how to transform familiar names like Ford and Intel into reliable monthly income generators.Claim Your Free Report Now: “Options Made Simple – 2 Affordable Stocks for Monthly Income” 2/12/20211,420,000 shares $317.21 million +8.4%2.8%3.6 $223.39 1/29/20211,310,000 shares $256.41 million +7.4%2.6%3 $195.73 1/15/20211,220,000 shares $258.95 million -9.0%2.4%2.8 $212.25 12/31/20201,340,000 shares $253.45 million -2.9%2.7%3.2 $189.14 12/15/20201,380,000 shares $254.04 million -10.4%2.8%3.2 $184.09 11/30/20201,540,000 shares $287.96 million -6.1%3.1%3.7 $186.99 11/15/20201,640,000 shares $337.18 million +12.3%3.4%4.1 $205.60 10/30/20201,460,000 shares $251.44 million -0.7%3.0%4 $172.22 10/15/20201,470,000 shares $249.66 million +9.7%3.0%3.8 $169.84 9/30/20201,340,000 shares $197.70 million -6.3%2.8%3.3 $147.54 9/15/20201,430,000 shares $214.89 million No Change3.0%2.6 $150.27 8/31/20201,430,000 shares $221.52 million +6.7%3.0%2.4 $154.91 8/14/20201,340,000 shares $192.81 million -23.4%2.8%2.1 $143.89 7/31/20201,750,000 shares $264.09 million +2.3%3.6%2.6 $150.91 7/15/20201,710,000 shares $213.48 million +8.9%3.5%2.6 $124.84 6/30/20201,570,000 shares $194.07 million -11.8%3.3%2.4 $123.61 6/15/20201,780,000 shares $202.83 million -8.7%3.7%3.2 $113.95 5/29/20201,950,000 shares $255.39 million -7.1%4.0%3.3 $130.97 5/15/20202,100,000 shares $295.01 million -16.7%4.4%3.5 $140.48 4/30/20202,520,000 shares $294.18 million -15.7%5.3%4.3 $116.74 4/15/20202,990,000 shares $306.98 million +9.9%6.3%5.4 $102.67 3/31/20202,720,000 shares $316.69 million +3.1%5.8%5.1 $116.43 3/13/20202,638,100 shares $261.04 million +28.7%5.6%4.1 $98.95 2/28/20202,050,000 shares $182.25 million -1.9%4.3%4.7 $88.90 2/14/20202,090,000 shares $200.35 million -11.8%4.4%5.3 $95.86 1/31/20202,370,000 shares $201.83 million -3.7%5.0%6.4 $85.16 1/15/20202,460,000 shares $258.72 million +1.7%5.2%6.2 $105.17 12/31/20192,420,000 shares $239.85 million -29.5%5.1%6.1 $99.11 RGEN Short Interest - Frequently Asked Questions What is Repligen's current short interest? Short interest is the volume of Repligen shares that have been sold short but have not yet been covered or closed out. As of November 15th, traders have sold 3,430,000 shares of RGEN short. 6.58% of Repligen's shares are currently sold short. Learn More on Repligen's current short interest. What is a good short interest ratio for Repligen? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RGEN shares currently have a short interest ratio of 5.0. Learn More on Repligen's short interest ratio. Which institutional investors are shorting Repligen? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Repligen: Jane Street Group LLC, Wolverine Trading LLC, Walleye Trading LLC, Walleye Capital LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Repligen? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.58% of Repligen's floating shares are currently sold short. Is Repligen's short interest increasing or decreasing? Repligen saw a increase in short interest in November. As of November 15th, there was short interest totaling 3,430,000 shares, an increase of 3.9% from the previous total of 3,300,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Repligen's float size? Repligen currently has issued a total of 56,030,000 shares. Some of Repligen's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Repligen currently has a public float of 52,100,000 shares. How does Repligen's short interest compare to its competitors? 6.58% of Repligen's shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Repligen: Alnylam Pharmaceuticals, Inc. (2.90%), Biogen Inc. (1.87%), United Therapeutics Co. (5.04%), Incyte Co. (3.69%), Neurocrine Biosciences, Inc. (4.19%), BioMarin Pharmaceutical Inc. (2.69%), Exact Sciences Co. (7.48%), Exelixis, Inc. (2.84%), Madrigal Pharmaceuticals, Inc. (20.31%), Halozyme Therapeutics, Inc. (8.30%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.85 billion), Charter Communications, Inc. ($4.81 billion), International Paper ($2.96 billion), Cencora, Inc. ($2.40 billion), Paychex, Inc. ($2.38 billion), Lululemon Athletica Inc. ($2.05 billion), SoFi Technologies, Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.93 billion), Onsemi ($1.82 billion), and Tractor Supply ($1.65 billion). View all of the most shorted stocks. What does it mean to sell short Repligen stock? Short selling RGEN is an investing strategy that aims to generate trading profit from Repligen as its price is falling. RGEN shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Repligen? A short squeeze for Repligen occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RGEN, which in turn drives the price of the stock up even further. How often is Repligen's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RGEN, twice per month. The most recent reporting period available is November, 15 2024. More Short Interest Resources from MarketBeat Related Companies Alnylam Pharmaceuticals Short Interest Biogen Short Interest United Therapeutics Short Interest Incyte Short Interest Neurocrine Biosciences Short Interest BioMarin Pharmaceutical Short Interest Exact Sciences Short Interest Exelixis Short Interest Madrigal Pharmaceuticals Short Interest Halozyme Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RGEN) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Repligen Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Repligen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.